[Skip to Content]

Upstate Active Clinical Trials

Study Title:

An Open-label, Phase 1b/2 Study of Acalabrutinib Alone or in Combination Therapy in Subjects with B-cell Non-Hodgkin Lymphoma

Upstate Institutional Review Board (IRB) Number:

1342978

Study/Protocol ID:

ACE-LY-003

Study Phase:

1b/2

Patient Age Group:

Adults

Principal Investigator:

Bernard J Poiesz, MD

ClinicalTrials.Gov ID:

NCT02180711

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Patricia M Benz
Phone: 315-464-8253
Email: benzp@upstate.edu

Return to Previous Page || Search Again

Top